These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34001267)

  • 21. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
    Chang FC; Chou YH; Chen YT; Lin SL
    J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels.
    Matsui K; Nagy-Bojarsky K; Laakkonen P; Krieger S; Mechtler K; Uchida S; Geleff S; Kang DH; Johnson RJ; Kerjaschki D
    J Am Soc Nephrol; 2003 Aug; 14(8):1981-9. PubMed ID: 12874451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic kidney disease induces a systemic microangiopathy, tissue hypoxia and dysfunctional angiogenesis.
    Prommer HU; Maurer J; von Websky K; Freise C; Sommer K; Nasser H; Samapati R; Reglin B; Guimarães P; Pries AR; Querfeld U
    Sci Rep; 2018 Mar; 8(1):5317. PubMed ID: 29593228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tipping the balance from angiogenesis to fibrosis in CKD.
    Ballermann BJ; Obeidat M
    Kidney Int Suppl (2011); 2014 Nov; 4(1):45-52. PubMed ID: 26312149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo analysis of microcirculation following closed soft-tissue injury.
    Schaser KD; Vollmar B; Menger MD; Schewior L; Kroppenstedt SN; Raschke M; Lübbe AS; Haas NP; Mittlmeier T
    J Orthop Res; 1999 Sep; 17(5):678-85. PubMed ID: 10569476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial Dysfunction in Renal Interstitial Fibrosis.
    Perry HM; Okusa MD
    Nephron; 2016; 134(3):167-171. PubMed ID: 27576317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial.
    Lundwall K; Jörneskog G; Jacobson SH; Spaak J
    Am J Nephrol; 2015; 42(4):265-73. PubMed ID: 26496210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis.
    Sun YB; Qu X; Caruana G; Li J
    Differentiation; 2016 Sep; 92(3):102-107. PubMed ID: 27262400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered vascular homeostasis in chronic kidney disease.
    Futrakul N; Butthep P; Futrakul P
    Clin Hemorheol Microcirc; 2008; 38(3):201-7. PubMed ID: 18239262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease.
    Burkhardt D; Bartosova M; Schaefer B; Grabe N; Lahrmann B; Nasser H; Freise C; Schneider A; Lingnau A; Degenhardt P; Ranchin B; Sallay P; Cerkauskiene R; Malina M; Ariceta G; Schmitt CP; Querfeld U
    PLoS One; 2016; 11(11):e0166050. PubMed ID: 27846250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing Microvascular Function in Humans from a Chronic Disease Perspective.
    Houben AJHM; Martens RJH; Stehouwer CDA
    J Am Soc Nephrol; 2017 Dec; 28(12):3461-3472. PubMed ID: 28904002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction.
    Fligny C; Duffield JS
    Curr Opin Rheumatol; 2013 Jan; 25(1):78-86. PubMed ID: 23196325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial injury and dysfunction: role in the extension phase of acute renal failure.
    Molitoris BA; Sutton TA
    Kidney Int; 2004 Aug; 66(2):496-9. PubMed ID: 15253696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults.
    Seliger SL; Salimi S; Pierre V; Giffuni J; Katzel L; Parsa A
    BMC Nephrol; 2016 Jul; 17(1):82. PubMed ID: 27412615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions.
    Akopov S; Sercombe R; Seylaz J
    Cerebrovasc Brain Metab Rev; 1996; 8(1):11-94. PubMed ID: 9052980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal microvascular disease predicts renal function in diabetes.
    Futrakul N; Futrakul P
    Ren Fail; 2012; 34(1):126-9. PubMed ID: 22010784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal endothelial injury and microvascular dysfunction in acute kidney injury.
    Verma SK; Molitoris BA
    Semin Nephrol; 2015 Jan; 35(1):96-107. PubMed ID: 25795503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
    Xu J; Wang J; Cheng Y; Li X; He M; Zhu J; Han H; Wei G; Kong H; Xie W; Wang H; Zuo X
    Biomed Res Int; 2018; 2018():1864107. PubMed ID: 29607314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives in renal disease progression: the endothelium as a treatment target in chronic kidney disease.
    Fliser D
    J Nephrol; 2010; 23(4):369-76. PubMed ID: 20349425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.